IJSRCH24914
IJSRCH24914
2Department of Chemistry, Tolani College of Arts & Science, Adipur, Gujarat, India
ARTICLEINFO ABSTRACT
Copyright © 2023 The Author(s): This is an open-access article distributed under the terms of the Creative
Commons Attribution 4.0 International License (CC BY-NC 4.0) which permits unrestricted use, distribution, and
reproduction in any medium for non-commercial use provided the original author and source are credited.
22
Dr. Bhavesh. L. Dodiya et al Int J Sci Res Chemi January-February-2024; 9 (1) : 22-32
II. REACTION SCHEME H), 7.26 (s, 2H, H), 7.40 (s, 2H, H), 7.89 (s, 1H, H),
R 8.80 (s, 1H, H),MS: m/z 378.
O O
O 1-benzyl-3-(2-morpholino-2-oxoacetyl)-1H-indole-2-
O
N OH MDC carboxylic acid (4b)
N OH Yield: 71%; mp 179ºC; Anal. Calcd. for C22H20N2O5:C,
i) (COCl2)
ii)Secondary amine
67.34; H, 5.14; N, 7.14; O, 20.39; Found: C, 67.31; H,
5.12; N, 7.13; O, 20.37%;IR (cm-1): 3111 (-NH), 3031 (-
R= secondary amine
CH of aromatic ring), 2992,2884 (-CH of CH3 group),
III. MATERIAL AND METHODS 1630 (C=O), 1521,1435(C=C) 1224 (C-N-C);1H NMR
(DMSO-d6) δ ppm:3.23(q, 2H, H), 3.67 (q, 4H, H),
General synthesis of 1H-Indole 3-yl-glyoxamide 3.53-3.59 (q, 2H, H), 3.80 (s, 2H, H), 6.92-7.09 (m, 5H,
derivatives. H), 7.21 (s, 2H, H), 7.31 (s, 2H, H), 7.81 (s, 1H, H),
General procedure for the preparation of 1-benzyl-3- 8.77 (s, 1H, H),MS: m/z 392.
(substituted secondary amine-2-oxoacetyl)-1H-indole- 1-benzyl-3-(2-oxo-2-(4-phenylpiperazin-1-yl)acetyl)-
2-carboxylic acid. To a stirred cooled (ice bath) 1H-indole-2-carboxylic acid (4c)
solution of 1-benzyl-1H-indole-2-carboxylic acid in Yield: 64%; mp 187ºC; Anal. Calcd. for C28H25N3O4:C,
dry DCM (20 ml), oxalyl chloride (1ml) was added 71.93; H, 5.39; N, 8.99; O, 13.69; Found: C, 71.99; H,
drop wise in solution. The obtained solution was 5.35; N, 8.959; O, 13.65%;IR (cm-1): 3123 (-NH), 3034
stirred at 0 C for 30.0 minute and then at 25-30 C for
o o
(-CH of aromatic ring), 2988,2881 (-CH of CH3 group),
2 hour. Dark yellow colored was formed. The solvent 1631 (C=O), 1532,1412(C=C) 1211 (C-N-C);1H NMR
was removed, the residue was dissolved in dry DCM (DMSO-d6) δ ppm:3.20 (q, 2H, H), 3.60 (q, 4H, H),
then add different secondary amine drop wise. The 3.51-3.56 (q, 2H, H), 3.77 (s, 2H, H), 6.92-7.51 (m,
reaction mixture was stirred at 0o C for 30.0 minute 10H, H), 7.77 (s, 2H, H), 8.13 (s, 2H, H), 10.11 (s, 1H,
and then 25-30o C for another 30.0 minute (monitored H),MS: m/z 467.
by TLC). The product was dissolved in water and 1-benzyl-3-(2-oxo-2-(piperidin-1-yl)acetyl)-1H-
extracted with ethyl acetate. The combined organic indole-2-carboxylic acid (4d)
layers were washed with water followed by brine and Yield: 69%; mp 184ºC; Anal. Calcd. for C23H22N2O4:C,
dried over anhydrous Na2SO4. The solid was treated 70.75; H, 5.68; N, 7.17; O, 16.39; Found: C, 70.74; H,
with hexane and resulting precipitate was filtered, 5.67; N, 7.17; O, 16.38%;IR (cm-1): 3102 (-NH), 3009 (-
washed with hexane and dried to give analytical pure CH of aromatic ring), 2985,2867 (-CH of CH3 group),
product. 1643 (C=O), 1535,1453(C=C) 1246 (C-N-C);1H NMR
Analytical Data (DMSO-d6) δ ppm:1.23 (q, 2H, H), 1.32 (q, 4H, H),
3-(aminoN,N-diethyl(formyl)form)-1-benzyl-1H- 3.53-3.59 (q, 2H, H), 3.76 (s, 2H, H), 3.88 (s, 2H, H),
indole-2-carboxylic acid (4a) 6.90-7.11 (m, 5H, H), 7.32 (s, 2H, H), 7.46 (s, 2H, H),
Yield: 74%; mp 175ºC; Anal. Calcd. for C22H22N2O4:C, 10.23 (s, 1H, H),MS: m/z 390.
69.83; H, 5.86; N, 7.40; Found: C, 69.80; H, 5.81; N, 1-benzyl-3-(2-(4-methylpiperazin-1-yl)-2-oxoacetyl)-
7.41%;IR (cm-1): 3109 (-NH), 3039 (-CH of aromatic 1H-indole-2-carboxylic acid (4e)
ring), 2993, 2880 (-CH of CH3 group), 1629 (C=O), Yield: 70%; mp 181ºC; Anal. Calcd. for C23H23N3O4:C,
1519, 1449 (C=C) 1259 (C-N-C); 1H NMR (DMSO-d6) 68.13; H, 5.72; N, 10.36; O, 15.78; Found: C, 68.10; H,
δ ppm:1.19-1.30 (dd’, 6H, H), 3.34-3.41 (q, 2H, H), 5.76; N, 10.35; O, 15.75%;IR (cm-1): 3113 (-NH), 3015
3.50-3.57 (q, 2H, H), 3.84 (s, 2H, H), 6.99-7.06 (m, 5H, (-CH of aromatic ring), 2976,2884 (-CH of CH3 group),
1653 (C=O), 1531,1444(C=C) 1231 (C-N-C);MS: m/z 1666 (C=O), 1540,1435(C=C) 1223 (C-N-C);MS: m/z
405. 406.
1-benzyl-3-(2-(4-ethylpiperazin-1-yl)-2-oxoacetyl)-
1H-indole-2-carboxylic acid (4f) Molecular docking
Yield: 75%; mp 188ºC; Anal. Calcd. for C24H25N3O4:C, Molecular docking was employed to investigate the
68.72; H, 6.01; N, 10.02; O, 15.26; Found: C, 68.74; H, binding mode between IND and BSA, using the
6.00; N, 10.04; O, 15.24%;IR (cm ): 3135 (-NH), 3022
-1 Molecular Operating Environment (MOE). The three-
(-CH of aromatic ring), 2974,2847 (-CH of CH3 group), dimensional crystal structure of BSA (PDB Code:
1646 (C=O), 1526,1438(C=C) 1211 (C-N-C);MS: m/z 4OR0) was obtained from the Protein Data Bank
419. (http://www.rcsb.org/pdb), while the structure of
1-benzyl-3-(2-(4-methylpiperidin-1-yl)-2-oxoacetyl)- IND was drawn using the MOE software. Energy
1H-indole-2-carboxylic acid(4g) optimization was conducted using the default force
Yield: 67%; mp 170ºC; Anal. Calcd. for C24H24N2O4:C, field MMFF94X method, with the RMS gradient set at
71.27; H, 5.98; N, 6.93; O, 15.82; Found: C, 71.24; H, 0.05 kcal mol−1. The rescoring functions utilized were
5.95; N, 6.90; O, 15.84%;IR (cm-1): 3133 (-NH), 3022 (- London dG and GBVI/WSA dG, denoted as rescoring
CH of aromatic ring), 2976,2863 (-CH of CH3 group), function 1 and 2, respectively. The selection of the
1663 (C=O), 1528,1446(C=C) 1224 (C-N-C);MS: m/z binding site on BSA was based on the results obtained
404. from site probe experiments.
1-benzyl-3-(2-(2-methylpiperidin-1-yl)-2-oxoacetyl)-
1H-indole-2-carboxylic acid (4h) IV. ADMET ANALYSIS
Yield: 70%; mp 170ºC; Anal. Calcd. for C24H24N2O4:C,
71.27; H, 5.98; N, 6.93; O, 15.82; Found: C, 71.29; H, The evaluation of Absorption, Distribution,
5.95; N, 6.91; O, 15.80%;IR (cm ): 3143 (-NH), 3035 (-
-1 Metabolism, Excretion, and Toxicity (ADMET)
CH of aromatic ring), 2988,2869 (-CH of CH3 group), properties plays a crucial role in drug discovery and
1648 (C=O), 1527,1441(C=C) 1235 (C-N-C);MS: m/z development. Understanding how a potential drug
404. candidate interacts with biological systems at various
1-benzyl-3-(2-oxo-2-(pyrrolidin-1-yl)acetyl)-1H- stages, from absorption into the bloodstream to
indole-2-carboxylic acid (4i) eventual elimination from the body, is paramount for
Yield: 64%; mp 170ºC; Anal. Calcd. for C22H20N2O4:CC, predicting its efficacy and safety profile. ADMET
70.20; H, 5.36; N, 7.44; O, 17.00; Found: C, 70.21; H, studies provide valuable insights into the
5.31; N, 7.41; O, 17.01%;IR (cm ): 3123 (-NH), 3020 (-
-1 pharmacokinetic and pharmacodynamic properties of
CH of aromatic ring), 2987,2896 (-CH of CH3 group), drug compounds, helping researchers prioritize lead
1651 (C=O), 1544,1438(C=C) 1240 (C-N-C);MS: m/z candidates and optimize their chemical structures to
376. enhance bioavailability, reduce toxicity, and improve
3-(aminoformyl-N,N-diisopropylform)-1-benzyl-1H- overall therapeutic outcomes. In this paper, we delve
indole-2-carboxylic acid (4J) into the significance of ADMET assessment in the
Yield: 70%; mp 180ºC; Anal. Calcd. for C24H26N2O4:C, drug discovery process, highlighting its importance in
70.92; H, 6.45; N, 6.89; O, 15.74; Found: C, 70.91; H, identifying promising drug candidates and guiding
6.43; N, 6.86; O, 15.71%;IR (cm-1): 3166 (-NH), 3033 (- rational drug design strategies for the treatment of
CH of aromatic ring), 2977,2864 (-CH of CH3 group), various diseases.
Serial dilutions were prepared in primary and 4a 300 500 350 400
600
500 Minimal inhibition
concentration (µg mL-1 )
400 Gram-positive S.a.
300 Minimal inhibition
concentration (µg mL-1 )
200
Gram-positive S. p.
100 Minimal inhibition
0 concentration (µg mL-1 )
Gram-negative E.c.
Norfloxacin
4f
4g
4a
4i
4j
4b
4c
4d
4e
4h
Ampicillin
Chloramphenicol
Minimal inhibition
concentration (µg mL-1 )
Gram-negative P.a.
Antibacterial Activity
The biological screening revealed that compound 4j exhibited maximum antibacterial activity against
gram-positive bacteria of Staphylococcus aureus. Compounds 4b showed minimum antibacterial activity.
Rests of the compounds were found to be good to moderate inhibitors against tested microbial strains.
600
500
Norfloxacin
4c
4e
4f
4g
4a
4i
4j
4b
4d
4h
Chloramphenicol
Ampicillin
concentration (µg mL-1 )
Fungal species A.c.
Antifungal Activity
Antifungal screening of these compound results that compound 4g showed good antifungal activity against
Candida albicans although remaining few compounds were decent to moderate inhibitors.
Molecular docking
Molecular docking of IND with BSA employing MOE, optimized using MMFF94X force field with RMS
gradient at 0.05 kcal/mol, and rescored using London dG and GBVI/WSA dG, with binding site selected
based on site probe experiments.
3D image Compound 4g at active site, dotted line indicates the -bond; pose view image of compound
3D image Compound 4f at active site, dotted line indicates the -bond; pose view image of compound
3D image Compound 4a at active site, dotted line indicates the -bond; pose view image of compound
2D image Compound 4a at active site, dotted line indicates the -bond; pose view image of compound
The results analysis reveals several notable findings regarding the binding affinities and interactions of the
tested compounds with the target receptor. Notably, Compound 4g demonstrated significant activity, despite
having a hydrogen bond distance of -3.4 Å, indicating a potential deviation from the typical hydrogen bond
formation. This compound exhibited a favorable free energy of binding (FEB) of -10.30 kcal/mol, suggesting a
strong binding affinity with the target receptor. Moreover, Compound 4g shares similar interacting atoms
(Ala316, Lys352, and Leu248) with gefitinib, which is known for its potent inhibitory activity against the target
receptor. This correlation suggests that the interactions facilitated by Compound 4g at these specific amino acid
residues may contribute to its observed activity.
Additionally, other compounds such as 4a, 4e, and 4h also demonstrated promising binding affinities with the
target receptor, as indicated by their low FEB values and estimated inhibition constants (Ki). These findings
underscore the potential of these compounds as effective inhibitors of the target receptor.
However, further experimental validation, including in vitro assays and structural studies, would be necessary
to confirm the inhibitory activity of Compound 4g and other promising candidates identified in this analysis.
Such studies could provide valuable insights into the structure-activity relationship (SAR) of these compounds
and aid in the rational design of novel therapeutic agents targeting the studied receptor.
ADMET
ADME parameters assessed for compounds, including LogP, MW, HBD, HBA, PSA, and number of rotatable
bonds, indicating drug-like characteristics and potential suitability for further development.
metal complexes, Polyhedron 81: 457-464. [11] Adwas A.A., Elkhoely A.A., Kabel A.M., Abdel-
doi.org/10.1016/j.poly.2014.06.057 Rahman M.N., Eissa A.A., (2016). Anticancer
[4] Ozdemir A., Altıntop M.D., Turan-Zitouni G., and cardioprotective effects of indol-3-carbinol
Çiftçi G.A., Ertorun I., Alatas O., Kaplancıklı in doxorubicin-treated mice, J. Infect.
Z.A., (2015). Synthesis and evaluation of new Chemother. 22: 36-43. DOI:
indole-based chalcones as potential 10.1016/j.jiac.2015.10.001
antiinflammatory agents, Eur. J. Med. Chem. 89: [12] Guan Q., Xing Y., Liu J., Wei W., Zhang R.,
304-309. DOI: 10.1016/j.ejmech.2014.10.056 Wang X., Bai F., (2013). Application of multiple
[5] Sharma V., Kumar P., Pathak D., (2010). parallel perfused microbioreactors: synthesis,
Biological importance of the indole nucleus in characterization and cytotoxicity testing of the
recent years: a Comprehensive review, J. novel rare earth complexes with indole acid as a
Heterocycl. Chem. 47: 491-502. ligand, J. Inorg. Biochem. 128: 57-67. DOI:
doi.org/10.1002/jhet.349 10.1016/j.jinorgbio.2013.07.018
[6] Singh N., Bhati S.K., Kumar A., (2008). [13] Abdulghani A.J., Hussain R.K., (2015). Synthesis
Thiazolyl/oxazolylformazanylindoles as potent and characterization of Schiff Base metal
anti-inflammatory agents, Eur. J. Med. Chem. complexes derived from cefotaxime with 1H-
43: 2597-2609. DOI: indole-2,3-dione (Isatin) and 4-N,N-dimethyl-
10.1016/j.ejmech.2007.12.024 aminobenzaldehyde, Open J. Inorg. Chem. 5:
[7] Baharfar R., Asghari S., Kiani M., (2015). 83-101. DOI: 10.4236/ojic.2015.54010
Regioselective synthesis and antibacterial [14] Zhang M., Chen Q., Yang G., (2015). A review
activity of 3-(cyanoacetyl) indole-based kojic on recent developments of indole containing
acid derivatives, Monatshefte Chem. 146: 335- antiviral agents, Eur. J. Med. Chem. 89: 421-
343. doi.org/10.1007/s00706-014-1310-x 441. DOI: 10.1016/j.ejmech.2014.10.065
[8] Bal T.R., Anand B., Yogeeswari P., Sriram D., [15] Dhanaraj C.J., Johnson J., (2017). DNA
(2005), Synthesis and evaluation of antiHIV interaction, antioxidant and in vitro cytotoxic
activity of isatin b-thiosemicarbazone activities of some mononuclear metal(II)
derivatives, Bioorg. Med. Chem. Lett, 15: 4451- complexes of a bishydrazone ligand, Mater. Sci.
4455. DOI: 10.1016/j.bmcl.2005.07.046 Eng. C78: 1006-1015. DOI:
[9] Radwan M.A.A., Ragab E.A., Sabry N.M., 10.1016/j.msec.2017.04.152
Shenawy S.M.E., (2007). Synthesis and
biological .evaluation of new 3-substituted
Cite this article as :
indole derivatives as potential antiinflammatory
Dr. Bhavesh. L. Dodiya, Dr. Haresh. K. Ram, Dr.
and analgesic agents, Bioorg. Med. Chem. 15:
Govind J Kher, Dr. Kaushik Joshi, Janaki H. Chauhan,
3832-3841. DOI: 10.1016/j.bmc.2007.03.024
"1-H-Indole-3-Glyoxamide Derivatives as Structurally
[10] Bhale P.S., Chavan H.V., Dongare S.B.,
Novel Bacterial Quorum Sensing Inhibitors; Molecular
Shringare S.N., NMule Y.B., Agane S.S., Bandgar
Docking, Admet Analysis, Design, Synthesis and
B.P., (2017). Synthesis of extended conjugated
Biological Evaluation", International Journal of
indolyl chalcones as potent anti-breast cancer,
Scientific Research in Chemistry (IJSRCH), ISSN :
anti-inflammatory and antioxidant agents,
2456-8457, Volume 9 Issue 1, pp. 22-32, January-
Bioorg. Med. Chem. Lett 27: 1502-1507. DOI:
February 2024.
10.1016/j.bmcl.2017.02.052
URL : https://ijsrch.com/IJSRCH24914